Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Publication of GB1257711ApublicationCriticalpatent/GB1257711A/en
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
A61K31/365—Lactones
Landscapes
Health & Medical Sciences
(AREA)
Chemical & Material Sciences
(AREA)
Medicinal Chemistry
(AREA)
Pharmacology & Pharmacy
(AREA)
Epidemiology
(AREA)
Life Sciences & Earth Sciences
(AREA)
Animal Behavior & Ethology
(AREA)
General Health & Medical Sciences
(AREA)
Public Health
(AREA)
Veterinary Medicine
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
1,257,711. Composition comprising plicatic acid lactone. H. H. ZINSSER. 3 March, 1969 [1 March, 1968], No. 11133/69. Heading A5B. A tablet for oral administration to a mammal for the prevention and treatment of oxalate urolithiasis comprises plicatic acid lactone of the general formula: and a nontoxic diluent.
3-phenyl-2-alkoxycarbonylaminophenyl-6(7)alkoxycarbonylamino-4-quinazolone derivatives,their production and pharmaceutical compositions containing them